CC
BMY.RT

Carlson Capital’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Carlson Capital’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-875,000
Closed -$604K – 225
2020
Q4 		$604K Sell
875,000
-293,896
-25% -$626K 0.02% 147
2020
Q3 		$2.63M Buy
1,168,896
+243,896
+26% +$697K 0.08% 157
2020
Q2 		$3.31M Buy
925,000
+490,000
+113% +$1.77M 0.09% 142
2020
Q1 		$1.65M Buy
435,000
+159,112
+58% +$524K 0.04% 164
2019
Q4 		$830K Buy
+275,888
New +$717K 0.02% 220

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.61B AUM 22.15% 1-Year Est. Return
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return